CLIMB BIO, INC. (CLYM) Net income 2020–2025
CLIMB BIO, INC. (CLYM) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$59.9MFY2025 · since FY2020: -$20.7M → -$59.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$59.9M | +19.0% |
| FY2024 | -$73.9M | -110.4% |
| FY2023 | -$35.1M | +22.4% |
| FY2022 | -$45.2M | +4.7% |
| FY2021 | -$47.5M | -129.7% |
| FY2020 | -$20.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CLYM financial trends
CLYM RevenueCLYM Net marginCLYM Gross profitCLYM Gross marginCLYM Operating incomeCLYM Operating marginCLYM Operating cash flowCLYM Free cash flowCLYM Capital expendituresCLYM Return on equityCLYM Stock buybacksCLYM Dividends paidCLYM Total assetsCLYM Total liabilitiesCLYM Shareholders’ equityCLYM overview →